Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04197583 · ClinicalTrials.gov registry record

Double-J PLUS Postmarket Registry Study

A clinical trial, sponsored by Boston Scientific Corporation.

Completed
Registry status
379
Enrollment target

NCT04197583 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 379 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04197583 has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
379 participants
Enrollment target

Study Summary

A multi-center global registry to obtain post-market safety and efficacy data on Boston Scientific Ureteral and Urinary Diversion Stents

Interventions

  • DEVICE Boston Scientific Ureteral Stents, Urinary Diversion Stent

Trial Details

FieldValue
Enrollment Target 379 participants
Start Date 2020-02-19
Est. Completion 2023-02-22

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT04197583

The ClinicalTrials.gov registry entry for NCT04197583 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 379 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Boston Scientific Ureteral Stents, Urinary Diversion Stent is the first listed.

NCT04197583 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04197583 about?

NCT04197583 is a clinical study titled "Double-J PLUS Postmarket Registry Study". A multi-center global registry to obtain post-market safety and efficacy data on Boston Scientific Ureteral and Urinary Diversion Stents

What is the current status of trial NCT04197583?

This trial is currently completed. The enrollment target is 379 participants. The study started on 2020-02-19. Estimated completion is 2023-02-22.

What interventions are being tested in trial NCT04197583?

The interventions under investigation include: Boston Scientific Ureteral Stents, Urinary Diversion Stent (DEVICE).

Who is sponsoring clinical trial NCT04197583?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.